Zinc for liver scarring in hepatitis B patients
Part of Digestive system, Infections clinical trials.
This study tests whether taking zinc sulfate can help reduce liver scarring in people with chronic hepatitis B who are already on antiviral medication. If you have moderate liver scarring, you may join to see if zinc improves your liver health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have chronic hepatitis B and are taking antiviral medication.
- Your liver has moderate scarring (called fibrosis stage F2 or F3).
- You have never had liver cancer or a liver transplant.
- You do not have HIV or hepatitis C.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests medicines to see whether they can reduce liver scarring (fibrosis) in people with long-term hepatitis C. If you qualify, you may receive the study treatment and be monitored over time to see how your liver is affected.
This trial tests whether atorvastatin (a cholesterol medicine) can lower the chance of liver cancer (HCC) in people with advanced liver scarring or cirrhosis. Participants are compared to placebo (inactive pill) while researchers track safety and cancer risk.
This trial tests whether taking zinc supplements can improve the outlook for people with a certain type of advanced liver disease that is still stable (no major complications). If you have compensated advanced chronic liver disease and meet the criteria, you might be able to join.
This study looks at how well different hepatitis B treatments help lower the risk of liver cancer. It's for people with chronic hepatitis B who are already using or starting certain antiviral or interferon therapies.
This trial tests a long-term treatment called hydronidone for liver scarring (fibrosis) caused by chronic hepatitis B. It aims to see if the treatment can help slow or reverse liver damage in people who are already on antiviral therapy or starting treatment for the first time.
This study tests different doses of zinc supplements combined with standard targeted therapy and immunotherapy for advanced liver cancer.
Hear when a new Liver Fibroses trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.